Helixmith reports Phase IIA data for Engensis to treat ALS
South Korea
Orum doses first subject in Phase I solid tumour drug trial
In the trial, the safety, pharmacokinetics, and initial anti-tumour activity of ORM-5029 will be assessed.
Genexine doses first subject in Phase II HNSCC combination therapy trial
Yuyu Pharma begins subject enrolment in Phase II dry eye disease study
SK bioscience Covid-19 vaccine active against BA.1 variant in Phase I/II trial
Elevar reports positive Phase II data of adenoid cystic carcinoma therapy
Hyundai Bioscience launches Phase II clinical trial of Covid-19 drug
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
